SG11202111102SA - Novel aav capsids and compositions containing same - Google Patents
Novel aav capsids and compositions containing sameInfo
- Publication number
- SG11202111102SA SG11202111102SA SG11202111102SA SG11202111102SA SG11202111102SA SG 11202111102S A SG11202111102S A SG 11202111102SA SG 11202111102S A SG11202111102S A SG 11202111102SA SG 11202111102S A SG11202111102S A SG 11202111102SA SG 11202111102S A SG11202111102S A SG 11202111102SA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions containing
- containing same
- aav capsids
- novel aav
- novel
- Prior art date
Links
- 210000000234 capsid Anatomy 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14142—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
- C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962840184P | 2019-04-29 | 2019-04-29 | |
| US201962913314P | 2019-10-10 | 2019-10-10 | |
| US201962924095P | 2019-10-21 | 2019-10-21 | |
| PCT/US2020/030266 WO2020223231A1 (en) | 2019-04-29 | 2020-04-28 | Novel aav capsids and compositions containing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202111102SA true SG11202111102SA (en) | 2021-11-29 |
Family
ID=73028724
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202111373YA SG11202111373YA (en) | 2019-04-29 | 2020-04-28 | Novel aav capsids and compositions containing same |
| SG11202111102SA SG11202111102SA (en) | 2019-04-29 | 2020-04-28 | Novel aav capsids and compositions containing same |
| SG11202111375RA SG11202111375RA (en) | 2019-04-29 | 2020-04-28 | Novel aav capsids and compositions containing same |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202111373YA SG11202111373YA (en) | 2019-04-29 | 2020-04-28 | Novel aav capsids and compositions containing same |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202111375RA SG11202111375RA (en) | 2019-04-29 | 2020-04-28 | Novel aav capsids and compositions containing same |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20220249705A1 (en) |
| EP (3) | EP3976078A4 (en) |
| JP (3) | JP2022530544A (en) |
| KR (3) | KR20220004681A (en) |
| CN (3) | CN113853209A (en) |
| AU (3) | AU2020264975A1 (en) |
| BR (3) | BR112021020054A2 (en) |
| CA (3) | CA3134507A1 (en) |
| CL (3) | CL2021002768A1 (en) |
| CO (3) | CO2021015928A2 (en) |
| IL (3) | IL287492A (en) |
| MX (3) | MX2021013266A (en) |
| PE (3) | PE20220014A1 (en) |
| SG (3) | SG11202111373YA (en) |
| WO (3) | WO2020223236A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3183153A1 (en) | 2020-06-17 | 2021-12-23 | Christian HINDERER | Compositions and methods for treatment of gene therapy patients |
| EP4200429A1 (en) | 2020-08-24 | 2023-06-28 | The Trustees of The University of Pennsylvania | Viral vectors encoding glp-1 receptor agonist fusions and uses thereof in treating metabolic diseases |
| WO2022094078A1 (en) | 2020-10-28 | 2022-05-05 | The Trustees Of The University Of Pennsylvania | Compositions useful in treatment of rett syndrome |
| CA3201533A1 (en) | 2020-11-11 | 2022-05-19 | European Molecular Biology Laboratory | Modified viral particles for gene therapy |
| CA3200192A1 (en) * | 2020-12-01 | 2022-06-09 | Justin PERCIVAL | Compositions and uses thereof for treatment of angelman syndrome |
| KR20230117157A (en) | 2020-12-01 | 2023-08-07 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | Novel composition having a tissue-specific targeting motif and composition comprising the same |
| AR125406A1 (en) | 2021-04-23 | 2023-07-12 | Univ Pennsylvania | NEW COMPOSITIONS WITH SELECTIVE MOTIVES FOR THE BRAIN AND COMPOSITIONS CONTAINING THEM |
| WO2023147304A1 (en) | 2022-01-25 | 2023-08-03 | The Trustees Of The University Of Pennsylvania | Aav capsids for improved heart transduction and detargeting of liver |
| WO2023168293A2 (en) * | 2022-03-01 | 2023-09-07 | The Trustees Of The University Of Pennsylvania | Viral vector genome encoding an insulin fusion protein |
| WO2023168403A2 (en) * | 2022-03-03 | 2023-09-07 | The Trustees Of The University Of Pennsylvania | Viral vectors encoding parathyroid hormone fusions and uses thereof in treating hypoparathyroidism |
| WO2023196892A1 (en) | 2022-04-06 | 2023-10-12 | The Trustees Of The University Of Pennsylvania | Passive immunization with anti- aav neutralizing antibodies to prevent off-target transduction of intrathecally delivered aav vectors |
| WO2023196893A1 (en) | 2022-04-06 | 2023-10-12 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treating her2 positive metastatic breast cancer and other cancers |
| WO2024015966A2 (en) * | 2022-07-15 | 2024-01-18 | The Trustees Of The University Of Pennsylvania | Recombinant aav having aav clade d and clade e capsids and compositions containing same |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2406745C (en) * | 2001-11-13 | 2006-01-10 | The Trustees Of The University Of Pennsylvania | A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| AU2004278684B2 (en) * | 2003-09-30 | 2011-05-12 | The Trustees Of The University Of Pennsylvania | Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor |
| CN112029737A (en) * | 2005-04-07 | 2020-12-04 | 宾夕法尼亚大学托管会 | Method for enhancing function of adeno-associated virus vector |
| CN101495624A (en) * | 2006-04-28 | 2009-07-29 | 宾夕法尼亚州立大学托管会 | Modified AAV vectors having reduced capsid immunogenicity and use thereof |
| CA3066596A1 (en) * | 2010-04-23 | 2011-10-27 | University Of Massachusetts | Cns targeting aav vectors and methods of use thereof |
| WO2015137802A1 (en) * | 2014-03-10 | 2015-09-17 | Uniqure Ip B.V. | Further improved aav vectors produced in insect cells |
| WO2015191508A1 (en) * | 2014-06-09 | 2015-12-17 | Voyager Therapeutics, Inc. | Chimeric capsids |
| AU2016206478A1 (en) * | 2015-01-16 | 2017-06-15 | Voyager Therapeutics, Inc. | Central nervous system targeting polynucleotides |
| ES2945427T3 (en) * | 2015-07-30 | 2023-07-03 | Massachusetts Eye & Ear Infirmary | Ancestral AAV sequences and their uses |
| WO2017075335A1 (en) * | 2015-10-28 | 2017-05-04 | Voyager Therapeutics, Inc. | Regulatable expression using adeno-associated virus (aav) |
| AU2016343979A1 (en) * | 2015-10-29 | 2018-05-10 | Voyager Therapeutics, Inc. | Delivery of central nervous system targeting polynucleotides |
| US11326182B2 (en) * | 2016-04-29 | 2022-05-10 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
| KR20240056729A (en) * | 2016-05-18 | 2024-04-30 | 보이저 테라퓨틱스, 인크. | Modulatory polynucleotides |
| US11192925B2 (en) * | 2016-10-19 | 2021-12-07 | Adverum Biotechnologies, Inc. | Modified AAV capsids and uses thereof |
| US10550405B2 (en) * | 2017-03-15 | 2020-02-04 | The University Of North Carolina At Chapel Hill | Rational polyploid adeno-associated virus vectors and methods of making and using the same |
| WO2018200419A1 (en) * | 2017-04-23 | 2018-11-01 | The Trustees Of The University Of Pennsylvania | Viral vectors comprising engineered aav capsids and compositions containing the same |
| JOP20190269A1 (en) * | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | Aadc polynucleotides for the treatment of parkinson's disease |
| US11512327B2 (en) * | 2017-08-03 | 2022-11-29 | Voyager Therapeutics, Inc. | Compositions and methods for delivery of AAV |
-
2020
- 2020-04-28 CA CA3134507A patent/CA3134507A1/en active Pending
- 2020-04-28 KR KR1020217037661A patent/KR20220004681A/en unknown
- 2020-04-28 BR BR112021020054A patent/BR112021020054A2/en unknown
- 2020-04-28 EP EP20798752.0A patent/EP3976078A4/en active Pending
- 2020-04-28 SG SG11202111373YA patent/SG11202111373YA/en unknown
- 2020-04-28 US US17/605,881 patent/US20220249705A1/en active Pending
- 2020-04-28 BR BR112021021502A patent/BR112021021502A2/en unknown
- 2020-04-28 BR BR112021020545A patent/BR112021020545A2/en unknown
- 2020-04-28 PE PE2021001788A patent/PE20220014A1/en unknown
- 2020-04-28 JP JP2021564542A patent/JP2022530544A/en active Pending
- 2020-04-28 WO PCT/US2020/030281 patent/WO2020223236A1/en active Application Filing
- 2020-04-28 CA CA3134379A patent/CA3134379A1/en active Pending
- 2020-04-28 JP JP2021564269A patent/JP2022530633A/en active Pending
- 2020-04-28 PE PE2021001789A patent/PE20212334A1/en unknown
- 2020-04-28 US US17/605,868 patent/US20220204990A1/en active Pending
- 2020-04-28 PE PE2021001795A patent/PE20212267A1/en unknown
- 2020-04-28 SG SG11202111102SA patent/SG11202111102SA/en unknown
- 2020-04-28 CN CN202080033196.8A patent/CN113853209A/en active Pending
- 2020-04-28 WO PCT/US2020/030266 patent/WO2020223231A1/en active Application Filing
- 2020-04-28 EP EP20798442.8A patent/EP3976077A4/en active Pending
- 2020-04-28 MX MX2021013266A patent/MX2021013266A/en unknown
- 2020-04-28 EP EP20798753.8A patent/EP3962507A4/en active Pending
- 2020-04-28 CN CN202080032773.1A patent/CN113853208A/en active Pending
- 2020-04-28 JP JP2021564543A patent/JP2022530656A/en active Pending
- 2020-04-28 MX MX2021013268A patent/MX2021013268A/en unknown
- 2020-04-28 CN CN202080032666.9A patent/CN113853207A/en active Pending
- 2020-04-28 SG SG11202111375RA patent/SG11202111375RA/en unknown
- 2020-04-28 AU AU2020264975A patent/AU2020264975A1/en active Pending
- 2020-04-28 KR KR1020217037659A patent/KR20220004680A/en unknown
- 2020-04-28 MX MX2021013267A patent/MX2021013267A/en unknown
- 2020-04-28 CA CA3134468A patent/CA3134468A1/en active Pending
- 2020-04-28 KR KR1020217038207A patent/KR20220004695A/en unknown
- 2020-04-28 WO PCT/US2020/030273 patent/WO2020223232A1/en active Application Filing
- 2020-04-28 AU AU2020266523A patent/AU2020266523A1/en active Pending
- 2020-04-28 US US17/605,874 patent/US20220220453A1/en active Pending
- 2020-04-28 AU AU2020264976A patent/AU2020264976A1/en active Pending
-
2021
- 2021-10-21 CL CL2021002768A patent/CL2021002768A1/en unknown
- 2021-10-21 IL IL287492A patent/IL287492A/en unknown
- 2021-10-21 IL IL287498A patent/IL287498A/en unknown
- 2021-10-21 IL IL287491A patent/IL287491A/en unknown
- 2021-10-26 CL CL2021002811A patent/CL2021002811A1/en unknown
- 2021-10-27 CL CL2021002824A patent/CL2021002824A1/en unknown
- 2021-11-25 CO CONC2021/0015928A patent/CO2021015928A2/en unknown
- 2021-11-25 CO CONC2021/0015924A patent/CO2021015924A2/en unknown
- 2021-11-25 CO CONC2021/0015916A patent/CO2021015916A2/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287492A (en) | Novel aav capsids and compositions containing same | |
| IL262214A (en) | Novel aav8 mutant capsids and compositions containing same | |
| EP3589277A4 (en) | Modified aav capsids and uses thereof | |
| EP4041755A4 (en) | Modified aav capsids and uses thereof | |
| IL286717A (en) | Immunotherapeutic compositions and use thereof | |
| IL287241A (en) | Compositions of exosomes and aav | |
| EP3820490A4 (en) | Aav compositions | |
| GB201904469D0 (en) | Cosmetic composition | |
| IL277786A (en) | Aav compositions, methods of making and methods of use | |
| ZA202105836B (en) | Cosmetic composition | |
| IL307957A (en) | Aav capsids and uses thereof | |
| IL285544A (en) | Compositions and methods for producing recombinant aav | |
| GB201909298D0 (en) | Novel compositions and uses thereof | |
| IL285916A (en) | Novel compositions and use thereof | |
| IL287316A (en) | Compounds and compositions | |
| GB2581344B (en) | Novel composition | |
| GB201906917D0 (en) | Novel compositions | |
| GB201901413D0 (en) | Compositions and their use | |
| GB201907230D0 (en) | Compounds and compositions and uses thereof | |
| GB201918142D0 (en) | Cosmetic composition | |
| GB201906906D0 (en) | Novel compositions | |
| GB201911461D0 (en) | Novel composition | |
| GB201910020D0 (en) | Novel composition | |
| GB201909264D0 (en) | Novel composition | |
| GB201904289D0 (en) | Compositions and uses thereof |